Optimus Pharma launched a new Anti-Parkinson’s Drug in India
Hyderabad (Telangana) [India], April 26: Optimus Pharma has announced today that it has received DCGI approval for its Anti-Parkinson’s drug Safinamide. Safinamide is indicated as adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease (PD) experiencing “off” episodes. The burdens of Parkinson’s Disease (PD) are undeniably serious and increasing while various unmet needs remain, especially…
Read More “Optimus Pharma launched a new Anti-Parkinson’s Drug in India” »